- Design
- Target trial emulation, French national discharge database, IPTW
- Population
- 1,872 adults with rectal cancer and synchronous liver metastases
- Primary outcome
- 30-day severe complications and overall survival
- Effect
- Severe complications adjusted OR 0.82 (95% CI 0.58-1.16); survival HR 0.88 (0.65-1.19)
The best order of surgery for rectal cancer with synchronous liver metastases is unsettled. This study emulated a target trial in the French national discharge database from 2014 to 2023, comparing combined resection with a staged approach (rectum first or liver first within 14 weeks).
Of 1,872 eligible patients, 73% had combined resection. Severe complications (Clavien-Dindo III or higher) occurred in 39.7% vs 45.3% (adjusted OR 0.82, 95% CI 0.58-1.16). Thirty-day mortality was 1.8% vs 1.5%. Median survival was 52.4 vs 57.3 months, with no significant difference after weighting (HR 0.88, 0.65-1.19). Major hepatectomy was independently associated with more severe complications (OR 1.81, 1.06-3.08).
This is observational data from an administrative database, weighted to resemble a trial. It cannot remove confounding by the surgeon's choice of strategy.
The practical reading: combined resection is a reasonable option, and the extent of the liver resection matters more to morbidity than the sequencing itself.
- Combined and staged resection were associated with similar severe-complication rates and survival.
- Major hepatectomy was the factor linked to more severe complications.
- Consider combined resection when the liver component is a minor resection.
- Make the sequencing decision in a multidisciplinary meeting, case by case.
- Administrative data cannot capture tumour burden fully, so confounding remains.
Why it matters
It gives rectal-specific evidence for a decision that has mostly been extrapolated from colon cancer.
Don't overread it
An emulated trial from discharge data is still observational and cannot prove the two strategies are equivalent.
The statistics, in plain English
Both intervals cross 1, so neither strategy was shown to be better or worse. The weighting balances measured factors only; unmeasured ones, such as how extensive the disease looked to the surgeon, can still bias the comparison.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for general surgery, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free